Back to News
Market Impact: 0.38

Roth/MKM reiterates Buy rating on Tesla stock, $505 target By Investing.com

TSLACF.TO
Analyst InsightsCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsAutomotive & EVTechnology & InnovationIPOs & SPACsMarket Technicals & Flows
Roth/MKM reiterates Buy rating on Tesla stock, $505 target By Investing.com

Roth/MKM reiterated a Buy on Tesla with a $505 price target, while the broader analyst range spans $125 to $600 and the stock trades at $370.34. The firm pointed to Q1 2026 demand strength, improved average selling price management, and a $5 billion increase in 2026 capex guidance to $25 billion, with a focus on growth projects like TerraFab. Debate around a pending SpaceX IPO and possible Tesla-SpaceX ties could keep sentiment volatile, even as Tesla has returned 54.55% over the past year.

Analysis

The market is implicitly re-rating Tesla as a growth + optionality story again, but the core tension is that multiple expansion is doing far more work than fundamentals. A 343x earnings multiple means even a small miss in delivery mix, price realization, or capex efficiency can compress the stock hard; the setup is less about operating momentum and more about whether incremental spending translates into visibly higher long-term unit economics over the next 2-4 quarters. The capex step-up is the key second-order variable. If this is genuinely tied to capacity and manufacturing leverage, it supports a future margin inflection; if it is pre-investment for speculative projects, then free cash flow becomes the pressure point and the equity starts trading more like a long-duration venture asset than an auto name. That matters because the marginal buyer on dips is likely momentum-driven, while the marginal seller on rallies will be valuation-sensitive institutions that can tolerate growth, but not an unconstrained reinvestment story. The SpaceX angle is not just narrative noise: it creates a near-term volatility catalyst and a potential cross-holder base effect. A SpaceX IPO could temporarily divert speculative capital away from TSLA, but it could also create a strategic linkage premium if investors price in shared customer demand, supply chain overlap, or optional corporate actions. The market is likely underpricing the probability that the IPO becomes a headline-driven catalyst regime rather than a fundamentals-driven one, which tends to widen implied volatility and make short-dated options structurally expensive. Contrarianly, the consensus is treating strong quarterly optics as evidence that the stock deserves to hold up despite richer valuation, but the more likely failure mode is not a bad quarter — it is capex disappointment and narrative fatigue. If growth initiatives do not show visible payoff within the next 6-12 months, the stock can re-rate lower even with decent operating prints. In that scenario, the upside is capped by optimistic analysts, while downside accelerates because there is no valuation buffer.